June 13, 2021 7:52 PM EDT

Send to a Friend

(Updated - June 14, 2021 2:54 AM EDT)

Citi analyst Yigal Nochomovitz upgraded CRISPR Therapeutics (NASDAQ: CRSP) from Sell ...

This is a premium only article. To continue reading this article and more like it please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE





Source link